WallStSmart

Nomura Holdings Inc ADR (NMR)vsOppenheimer Holdings Inc (OPY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 132767% more annual revenue ($2.17T vs $1.63B). NMR leads profitability with a 16.7% profit margin vs 6.0%. NMR appears more attractively valued with a PEG of 0.82. NMR earns a higher WallStSmart Score of 70/100 (B-).

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

OPY

Strong Buy

66

out of 100

Grade: B-

Growth: 8.7Profit: 5.5Value: 5.7Quality: 4.8
Piotroski: 5/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

OPY4 strengths · Avg: 9.5/10
P/E RatioValuation
11.6x10/10

Attractively priced relative to earnings

Price/BookValuation
1.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
588.0%10/10

Earnings expanding 588.0% YoY

Revenue GrowthGrowth
23.1%8/10

Revenue surging 23.1% year-over-year

Areas to Watch

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

OPY4 concerns · Avg: 2.8/10
Market CapQuality
$1.07B3/10

Smaller company, higher risk/reward

Profit MarginProfitability
6.0%3/10

6.0% margin — thin

Debt/EquityHealth
1.493/10

Elevated debt levels

PEG RatioValuation
12.002/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bull Case : OPY

The strongest argument for OPY centers on P/E Ratio, Price/Book, EPS Growth. Revenue growth of 23.1% demonstrates continued momentum.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Bear Case : OPY

The primary concerns for OPY are Market Cap, Profit Margin, Debt/Equity.

Key Dynamics to Monitor

OPY carries more volatility with a beta of 1.09 — expect wider price swings.

NMR is growing revenue faster at 27.5% — sustainability is the question.

OPY generates stronger free cash flow (-204M), providing more financial flexibility.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (70/100 vs 66/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Oppenheimer Holdings Inc

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Oppenheimer Holdings Inc. is a middle market investment bank and full service stockbroker in the Americas, Europe, the Middle East and Asia. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?